Research Peptide Comparison
GHK-Cu 100mg and Glow (Glutathione) 70mg are both Anti-Aging research peptides available from Neovia Peptides. This comparison highlights the key differences in specifications, pricing, and availability to help inform your research decisions.
GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine:Cu²⁺) present endogenously in human plasma, saliva and urine, with circulating concentrations diminishing measurably with age. The literature characterises its influence on extracellular matrix remodelling, fibroblast activation and broad transcriptomic modulation across genes linked to repair, antioxidant defence and angiogenesis.
Compared to Glow (Glutathione) 70mg, GHK-Cu 100mg is priced at £34.99 with 99%+ verified purity. Its CAS registry number is 49557-75-7. It has a molecular weight of 403.93 g/mol.
GHK-Cu 100mg is available in 50mg, 100mg and ships with a full Certificate of Analysis from Janoshik Analytical. At £25.00 less than Glow (Glutathione) 70mg, it is the more affordable option in this comparison.
Glutathione (GSH) is the predominant intracellular thiol-bearing tripeptide, composed of γ-glutamyl-cysteinyl-glycine, and serves as the master antioxidant and substrate for glutathione peroxidases, S-transferases, and the glyoxalase system. It governs redox homeostasis, phase-II detoxification, and protein S-glutathionylation signalling, making it central to oxidative-stress and longevity research.
Compared to GHK-Cu 100mg, Glow (Glutathione) 70mg is priced at £59.99 with 99%+ verified purity. Its CAS registry number is 70-18-8. It has a molecular weight of 307.32 g/mol.
Glow (Glutathione) 70mg is available in single size and ships with a full Certificate of Analysis from Janoshik Analytical. It is priced £25.00 higher than GHK-Cu 100mg.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
